Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I3 | Q14994 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.62 |
| ▸ | SHBG | P04278 | 1/20 | 0.62 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | GABRP | O00591 | 1/20 | 0.55 |
| ▸ | GABRD | O14764 | 1/20 | 0.55 |
| ▸ | GMNN | O75496 | 1/20 | 0.55 |
| ▸ | G6PD | P11413 | 1/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Androstenol SCHEMBL3163766 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL324888 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL8817019 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL5072488 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL9543417 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL8817023 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL3163769 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL3365124 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL14360552 | 1.00 | NR1I3 (1.00) | NR1I3ALDH1A1LMNAGPBAR1SHBG | |
| Androstenol SCHEMBL27501533 | 0.88 | KDM4E (0.81) | NR1I3ALDH1A1LMNAGPBAR1SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118620014-A | Synthesis method of natural pig ectohormone androstane-16-alkene-3 alpha-alcohol | 嘉兴学院 | 2024-09-10 | — | — | CN | claimed |
| EP-2938402-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2015-11-04 | — | — | EP | claimed |
| EP-2938654-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2015-11-04 | — | — | EP | claimed |
| WO-2014102078-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2014-07-03 | — | — | WO | claimed |
| WO-2014102077-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2014-07-03 | — | — | WO | claimed |
| CN-118620014-A | Synthesis method of natural pig ectohormone androstane-16-alkene-3 alpha-alcohol | 嘉兴学院 | 2024-09-10 | — | — | CN | disclosed |
| CN-118620014-A | Synthesis method of natural pig ectohormone androstane-16-alkene-3 alpha-alcohol | 嘉兴学院 | 2024-09-10 | — | — | CN | disclosed |
| EP-3538058-A1 | DEODORIZING AGENT COMPRISING ZINC NEODECANOATE | Givaudan SA (CH) | 2019-09-18 | — | — | EP | disclosed |
| WO-2018087147-A1 | DEODORIZING AGENT COMPRISING ZINC NEODECANOATE | GIVAUDAN SA (CH) | 2018-05-17 | — | — | WO | disclosed |
| WO-2012064557-A2 | DEODORIZING COMPOSITIONS | LIPO CHEMICALS INC. (US) | 2012-05-18 | — | — | WO | disclosed |
| EP-0914165-A4 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY | PHERIN PHARM INC (US) | 2004-01-21 | — | — | EP | disclosed |
| EP-0715517-A4 | ESTRENE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS | PHERIN CORP (US) | 2000-10-11 | — | — | EP | disclosed |
| EP-0914165-A1 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY | Pherin Pharmaceuticals, Inc. (US) | 1999-05-12 | — | — | EP | disclosed |
| WO-1998014194-A9 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF ANXIETY | — | 1998-08-27 | — | — | WO | disclosed |
| WO-1998003207-A9 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY | — | 1998-05-22 | — | — | WO | disclosed |
| WO-1998014194-A1 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF ANXIETY | PHERIN PHARMACEUTICALS (US) | 1998-04-09 | — | — | WO | disclosed |
| WO-1998003207-A1 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY | PHERIN PHARMACEUTICALS, INC. (US) | 1998-01-29 | — | — | WO | disclosed |
| EP-0715517-A1 | ESTRENE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS | PHERIN CORPORATION (US) | 1996-06-12 | — | — | EP | disclosed |
| WO-1994028903-A1 | ESTRENE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS | PHERIN CORPORATION (US) | 1994-12-22 | — | — | WO | disclosed |
| WO-1993018742-A1 | FRAGRANCE COMPOSITIONS AND OTHER COMPOSITIONS WHICH CONTAIN HUMAN PHEROMONES | EROX CORPORATION (US) | 1993-09-30 | — | — | WO | disclosed |